Download Sample
Add to CartGlobal Neurological Biomarkers Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Product Type;
Genomics Biomarker, Proteomics Biomarker, Imaging Biomarker, Metabolomics Biomarker and Others.Segmented by End User;
Clinical Diagnostics, Pharmaceutical And Biotechnology Companies, Research Organizations and Surgical Center.Segmented by Indication;
Spinal Muscular Atrophy, Parkinson’s Disease, Schizophrenia, Huntington’s Disease, Alzheimer’s Disease, Depression and Multiple Sclerosis.Segmented by Imaging Techniques;
Transcranial Magnetic Stimulation, Diffusion Tensor Imaging, Conventional Structural MRI, Functional Magnetic Resonance Imaging and Positron Emission Tomography.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Neurological Biomarkers Market (USD Million), 2020 - 2030
| # | Global |
|---|---|
| 2020 | 57.4 |
| 2021 | 62.5 |
| 2022 | 66.8 |
| 2023 | 73.7 |
| 2024 | 85.8 |
| 2025 | 96.2 |
| 2026 | 105.2 |
| 2027 | 111.5 |
| 2028 | 119.8 |
| 2029 | 132.1 |
| 2030 | 151.4 |
In the year 2023, the Global Neurological Biomarkers Market was valued at USD 8,846.12 million. The size of this market is expected to increase to USD 19,192.20 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 11.7%.
Global Neurological Biomarkers Market Report Snapshot
| Parameters | Description |
|---|---|
| Market | Global Neurological Biomarkers Market |
| Study Period | 2020 - 2030 |
| Base Year (for Neurological Biomarkers Market Size Estimates) | 2023 |
| Study Scope |
|
| Market Segmentation |
|
| Geographical Coverage |
|
| Company Coverage |
|
| Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Neurological Biomarkers Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Neurological Biomarkers Market Analysis
In this report, the Global Neurological Biomarkers Market has been segmented by Product Type, End User, Indication, Imaging Techniques and Geography.
Global Neurological Biomarkers Market, Segmentation by Product Type
The Global Neurological Biomarkers Market has been segmented by Product Type into Genomics Biomarker, Proteomics Biomarker, Imaging Biomarker, Metabolomics Biomarker and Others. The complete Global Neurological Biomarkers Market segmentation by Product Type can be seen below:
- Global Neurological Biomarkers Market, By Product Type
- Genomics Biomarker
- Proteomics Biomarker
- Imaging Biomarker
- Metabolomics Biomarker
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Product Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neurological Biomarkers Market, by Product Type (USD Million), 2020 - 2030
| # | Genomics Biomarker | Proteomics Biomarker | Imaging Biomarker | Metabolomics Biomarker | Others |
|---|---|---|---|---|---|
| 2020 | 77.5 | 92.6 | 68.5 | 81.5 | 69.3 |
| 2021 | 77.8 | 104.4 | 69.9 | 83.9 | 82.4 |
| 2022 | 78.6 | 107.1 | 78.7 | 100.0 | 91.4 |
| 2023 | 92.5 | 113.6 | 80.2 | 101.4 | 96.9 |
| 2024 | 97.5 | 120.7 | 81.8 | 103.1 | 99.3 |
| 2025 | 105.6 | 130.9 | 90.3 | 113.6 | 106.4 |
| 2026 | 118.6 | 154.9 | 92.6 | 132.5 | 118.2 |
| 2027 | 137.4 | 181.1 | 98.3 | 141.1 | 131.3 |
| 2028 | 142.4 | 181.3 | 113.7 | 150.4 | 156.7 |
| 2029 | 151.6 | 200.2 | 130.1 | 151.1 | 181.7 |
| 2030 | 169.5 | 207.6 | 130.2 | 168.4 | 205.1 |
Global Neurological Biomarkers Market, Segmentation by End User
The Global Neurological Biomarkers Market has been segmented by End User into Clinical Diagnostics, Pharmaceutical And Biotechnology Companies, Research Organizations and Surgical Center. The complete Global Neurological Biomarkers Market segmentation by End User can be seen below:
- Global Neurological Biomarkers Market, By End User
- Clinical Diagnostics
- Pharmaceutical And Biotechnology Companies
- Research Organizations
- Surgical Center
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Users mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End User is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neurological Biomarkers Market, by End User (USD Million), 2020 - 2030
| # | Clinical Diagnostics | Pharmaceutical And Biotechnology Companies | Research Organizations | Surgical Center |
|---|---|---|---|---|
| 2020 | 55.4 | 84.3 | 112.1 | 97.2 |
| 2021 | 60.8 | 98.1 | 116.0 | 106.1 |
| 2022 | 65.7 | 111.6 | 128.8 | 107.8 |
| 2023 | 66.9 | 129.4 | 137.7 | 117.3 |
| 2024 | 67.3 | 132.3 | 141.7 | 129.5 |
| 2025 | 75.3 | 152.3 | 146.6 | 142.1 |
| 2026 | 82.4 | 180.5 | 174.0 | 159.5 |
| 2027 | 98.1 | 214.9 | 190.3 | 182.7 |
| 2028 | 110.8 | 239.0 | 195.0 | 207.7 |
| 2029 | 112.8 | 246.4 | 221.8 | 209.7 |
| 2030 | 114.9 | 276.6 | 264.0 | 212.1 |
Global Neurological Biomarkers Market, Segmentation by Indication
The Global Neurological Biomarkers Market has been segmented by Indication into Spinal Muscular Atrophy, Parkinsons Disease, Schizophrenia, Huntingtons Disease, Alzheimers Disease, Depression and Multiple Sclerosis. The complete Global Neurological Biomarkers Market segmentation by Indication can be seen below:
- Global Neurological Biomarkers Market, By Indication
- Spinal Muscular Atrophy
- Parkinsons Disease, Schizophrenia
- Huntingtons Disease
- Alzheimers Disease
- Depression
- Multiple Sclerosis
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Indications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Indication is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neurological Biomarkers Market, by Indication (USD Million), 2020 - 2030
| # | Spinal Muscular Atrophy | Parkinsons Disease, Schizophrenia | Huntingtons Disease | Alzheimers Disease | Depression | Multiple Sclerosis |
|---|---|---|---|---|---|---|
| 2020 | 52.7 | 64.2 | 72.8 | 89.7 | 86.1 | 55.9 |
| 2021 | 59.5 | 65.0 | 85.0 | 99.1 | 90.0 | 65.8 |
| 2022 | 63.3 | 75.2 | 88.6 | 115.3 | 92.7 | 71.6 |
| 2023 | 71.5 | 78.6 | 102.9 | 120.5 | 110.5 | 80.3 |
| 2024 | 74.7 | 79.3 | 106.5 | 128.2 | 127.9 | 87.2 |
| 2025 | 77.8 | 94.2 | 110.9 | 130.8 | 149.0 | 91.7 |
| 2026 | 86.0 | 100.4 | 111.5 | 149.7 | 149.5 | 92.7 |
| 2027 | 99.5 | 106.0 | 131.0 | 156.1 | 162.0 | 101.0 |
| 2028 | 118.0 | 121.4 | 152.8 | 182.7 | 172.5 | 115.7 |
| 2029 | 131.4 | 139.3 | 173.2 | 190.7 | 184.2 | 131.2 |
| 2030 | 146.5 | 156.0 | 178.3 | 223.9 | 216.6 | 147.1 |
Global Neurological Biomarkers Market, Segmentation by Imaging Techniques
The Global Neurological Biomarkers Market has been segmented by Imaging Techniques into Transcranial Magnetic Stimulation, Diffusion Tensor Imaging, Conventional Structural MRI, Functional Magnetic Resonance Imaging and Positron Emission Tomography. The complete Global Neurological Biomarkers Market segmentation by Imaging Techniques can be seen below:
- Global Neurological Biomarkers Market, By Imaging Techniques
- Transcranial Magnetic Stimulation
- Diffusion Tensor Imaging, Conventional Structural MRI
- Functional Magnetic Resonance Imaging
- Positron Emission Tomography
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Imaging Techniquess mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Imaging Techniques is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neurological Biomarkers Market, by Imaging Techniques (USD Million), 2020 - 2030
| # | Transcranial Magnetic Stimulation | Diffusion Tensor Imaging, Conventional Structural MRI | Functional Magnetic Resonance Imaging | Positron Emission Tomography |
|---|---|---|---|---|
| 2020 | 67.0 | 67.7 | 102.3 | 90.7 |
| 2021 | 72.1 | 73.4 | 105.4 | 106.3 |
| 2022 | 78.8 | 75.5 | 118.4 | 113.8 |
| 2023 | 87.1 | 80.4 | 133.5 | 122.0 |
| 2024 | 103.6 | 85.2 | 148.7 | 123.4 |
| 2025 | 105.5 | 98.5 | 164.8 | 140.4 |
| 2026 | 123.6 | 117.8 | 166.1 | 166.9 |
| 2027 | 135.8 | 139.3 | 191.6 | 185.4 |
| 2028 | 152.0 | 154.1 | 227.9 | 193.0 |
| 2029 | 159.7 | 163.4 | 269.0 | 211.7 |
| 2030 | 168.8 | 173.2 | 314.3 | 232.9 |
Global Neurological Biomarkers Market, Segmentation by Geography
In this report, the Global Neurological Biomarkers Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Neurological Biomarkers Market Share (%), by Geographical Region, 2023
| North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Neurological Biomarkers Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Neurological Biomarkers in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Neurological Biomarkers Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Neurological Biomarkers Market is driven by; Increasing demand for non-invasive diagnostic techniques for Alzheimers and Parkinsons will drive the market growth, Growing demand for personalized medicine for neurological disorders also accelerates the market growth, Rising focus to create cost- effective biomarker testing will also propel the growth and Growing demand for genomics biomarker will also propel the market growth.
- While the growth of Global Neurological Biomarkers Market is currently hindered by; Strict government regulation will hamper the market growth, Emerging legal issues with early diagnosis of Alzheimer's and Parkinson's diseases also acts as a restricting factor for the growth of this market and The absence of pre-analytical tests will also hinder the market growth.
- The new opportunities in Global Neurological Biomarkers Market will be discussed in detail in the full report.
- Increasing demand for non-invasive diagnostic techniques for Alzheimers and Parkinsons will drive the market growth.
- Growing demand for personalized medicine for neurological disorders also accelerates the market growth.
- Rising focus to create cost- effective biomarker testing will also propel the growth.
- Growing demand for genomics biomarker will also propel the market growth.
- Strict government regulation will hamper the market growth.
- Emerging legal issues with early diagnosis of Alzheimer's and Parkinson's diseases also acts as a restricting factor for the growth of this market.
- The absence of pre-analytical tests will also hinder the market growth.
- Global Neurological Biomarkers Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Neurological Biomarkers Market. The opportunity map (by market segments; Product Type, End User, Indication and Imaging Techniques) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Neurological Biomarkers Market, Opportunity Map, By Region (2020 - 2030)
| North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Neurological Biomarkers Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Neurological Biomarkers Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Neurological Biomarkers Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
| Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Neurological Biomarkers Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
| Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
|---|---|---|---|---|
| 10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Neurological Biomarkers Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
| Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
|---|---|---|---|---|
| 20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Neurological Biomarkers Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
| Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
|---|---|---|---|---|---|
| 2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Neurological Biomarkers Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
| Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
|---|---|---|---|---|
| 5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Neurological Biomarkers Market include, Myriad RBM, Abbott, Thermo Fisher Scientific Inc, Athena Diagnostics, Inc, Quanterix; Immunarray Pvt. Ltd, QIAGEN, Bio-Rad Laboratories, Inc, BANYAN BIOMARKERS, INC, Merck KGaA, F. Hoffmann-La Roche Ltd, Janssen Global Services, LLC, Charles River, Advanced Brain Monitoring, Inc, Neurosteer and Quanterix.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
| Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product 1/Service 1 | ||||||||||
| Product 2/Service 2 | ||||||||||
| Product 3/Service 3 | ||||||||||
| Product 4/Service 4 | ||||||||||
| Product 5/Service 5 | ||||||||||
| Product 6/Service 6 | ||||||||||
| Product 7/Service 7 | ||||||||||
| Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Indication
- Market Snapshot, By Imaging Techniques
- Market Snapshot, By Region
- Market Opportunity Map
- Global Neurological Biomarkers Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing demand for non-invasive diagnostic techniques for Alzheimer’s and Parkinson’s will drive the market growth
- Growing demand for personalized medicine for neurological disorders also accelerates the market growth
- Rising focus to create cost- effective biomarker testing will also propel the growth
- Growing demand for genomics biomarker will also propel the market growth
- Restraints
- Strict government regulation will hamper the market growth
- Emerging legal issues with early diagnosis of Alzheimer's and Parkinson's diseases also acts as a restricting factor for the growth of this market
- The absence of pre-analytical tests will also hinder the market growth
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Neurological Biomarkers Market, By Product Type, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Genomics Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Proteomics Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Imaging Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Metabolomics Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Genomics Biomarker
- Global Neurological Biomarkers Market, By End User, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmaceutical And Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Clinical Diagnostics
- Global Neurological Biomarkers Market, By Indication, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Spinal Muscular Atrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Parkinson’s Disease, Schizophrenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Huntington’s Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Alzheimer’s Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Spinal Muscular Atrophy
- Global Neurological Biomarkers Market, By Imaging Techniques, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Transcranial Magnetic Stimulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Diffusion Tensor Imaging, Conventional Structural MRI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Functional Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Positron Emission Tomography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Transcranial Magnetic Stimulation
- Global Neurological Biomarkers Market, By Geography, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Techniques, 2020 - 2030 (USD Million)
- Brazil
- North America
- Global Neurological Biomarkers Market, By Product Type, 2020 - 2030 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Myriad RBM
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Thermo Fisher Scientific Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Athena Diagnostics, Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Quanterix; Immunarray Pvt. Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- QIAGEN
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bio-Rad Laboratories, Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- BANYAN BIOMARKERS, INC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck KGaA
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Janssen Global Services, LLC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Charles River
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Advanced Brain Monitoring, Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Neurosteer
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Quanterix
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Myriad RBM
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Neurology Ultrasonic Aspirators Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Neuromorphic Computing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Neurosurgery Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global New Born Eye Imaging Systems Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%